IP Library Patent Application 11387402
Patent Application
App. No. 11/387,402

Biodegradable polymeric material for biomedical applications

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/387,402
Abstract

The invention relates to a poly(ether ester) multiblock copolymer material based on a combination of a poly(alkylene glycol) component, a short chain diol, an aromatic dicarboxylic acid or derivative thereof and at least one type of non-aromatic dicarboxylic acid or derivative thereof. The invention further relates to a process for the preparation of the polymeric material, a medical device comprising said polymeric material and the use of the medical device for the preparation of a medicament for guided tissue regeneration, as a scaffold for engineering tissue in vitro, or as a matrix for controlled release of a (bio)active substance.

Claims (21)

1 - 13 . (canceled)

14 . An apparatus for use in vivo comprising an implantable or ingestible medical device, the medical device comprising a random copolymer including monomeric units:

wherein

* represents a linkage to another monomeric unit,

X represents a moiety containing an aromatic group;

Y is an alkylene moiety;

Z represents an alkylene or alkenylene moiety;

n is an integer in the range of 1-250: and

m is an integer in the range of 2-16.

15 . The medical device according to claim 14 , wherein said medical device is selected from the group consisting of a scaffold for engineering tissue in vitro, a matrix for controlled drug release, a substitute for tissue repair, a suture, a bone screw, a suture anchor, a tapered or non-tapered pin, and a staple.

16 - 17 . (canceled)

18 . A method for repairing tissue comprising providing the medical device according to claim 14 to a patient in need thereof.

19 . The medical device according to claim 14 , wherein a combined weight fraction of the monomeric units A and C of the copolymer lies in the range of 0.1 to 1.

20 . The medical device according to claim 14 , wherein a combined weight fraction of the sum of the number of monomeric units C and the number of monomeric units D is from 0.1 to 1.

21 . The medical device according to claim 14 , wherein a combined weight fraction of the sum of the number of monomeric units C and the number of monomeric units D is from 0.05 to 0.99.

22 . The medical device according to claim 14 , wherein X in the copolymer is a phenyl group.

23 . The medical device according to claim 14 , wherein Y in the copolymer is selected from the group consisting of ethylene, propylene, butylene and combinations thereof.

24 . The medical device according to claim 14 , wherein Z in the copolymer is selected from the group consisting of ethenylene, propylene, butylenes, hexylene, and octylene.

25 . The medical device according to claim 14 , wherein n is an integer in the range of 8-100.

26 . The medical device according to claim 14 , wherein the copolymer has a weight average molecular weight of from 10,000 to 500,000 g/mol.

27 . The medical device according to claim 14 , wherein the copolymer has a weight average molecular weight of from 40,000 to 300,000 g/mol.

Assignments (3)
TERMINATION OF SECURITY INTEREST Recorded Oct 14, 2008
From: BIOLEX THERAPEUTICS, INC.
To: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
Reel/Frame 021701/0168 →
SECURITY AGREEMENT Recorded Jul 15, 2008
From: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 021230/0881 →
SECURITY AGREEMENT Recorded May 30, 2008
From: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
To: LSP III OMNI INVESTMENT COOPERATIEF U.A.; S.R. ONE, LIMITED
Reel/Frame 021018/0559 →